NASDAQ
Alterola Biotech, Inc. (ABTI) has a free cash flow growth of -29.45% as of Friday, May 29, 2026. This represents a 69.57% increase compared to its 12-month average of -96.79%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.